Login / Signup

Unusual Clinical Manifestations in a Mexican Patient with Sanfilippo B Syndrome.

Liliana Fernández-HernándezMiriam Erandi Reyna-FabiánMiguel Angel Alcántara-OrtigozaCarmen Aláez-VersonLuis L Flores-LagunesKarol Carrillo-SánchezAriadna González-Del Angel
Published in: Diagnostics (Basel, Switzerland) (2022)
We present an unusual Mexican patient affected with mucopolysaccharidosis type IIIB (MPS IIIB; also called Sanfilippo B syndrome, MIM #252920) bearing clinical features that have not previously been described for MPS IIIB (growth arrest, hypogonadotropic hypogonadism, and congenital heart disease). Chromosomal microarray analysis was useful in identifying runs of homozygosity at 17q11.1-q21.33 and supporting the diagnosis of an underlying autosomal recessive condition. Sanger sequencing of NAGLU (17q21.2, MIM*609701) allowed us to identify a pathogenic homozygous p.(Arg234Cys) genotype. This NAGLU allele could be related to that previously described in an Iberian MPS IIIB founder haplotype; results from the polymorphic marker D17S800 and rs2071046 led us to hypothesize that it may have been introduced to Mexico through the Spanish settlement. The analysis of a clinical exome sequencing ruled out other monogenic etiologies for the previously undescribed clinical MPS IIIB manifestations. Our findings contribute to further delineating the MPS IIIB phenotype and suggest possible phenotype-genotype correlations.
Keyphrases
  • congenital heart disease
  • case report
  • copy number
  • gene expression
  • high throughput sequencing